Drugs News and Research

RSS

Many heart attack patients still not getting emergency reperfusion

Far more of today's heart attack patients receive emergency angioplasty treatment or clot-busting drugs to re-open their clogged heart arteries than even a decade ago, a new study finds.

6 Aug 2007

Emergency angioplasty use rises, but some patients still miss out

Compared with their counterparts a decade ago, today's heart attack patients are receiving emergency angioplasty or clot-busting drugs to re-open clogged arteries at a far greater rate, but 10 percent of patients who could benefit from this life-saving treatment still do not receive it, according to a study published in The American Journal of Medicine by Yale and University of Michigan researchers.

6 Aug 2007

Determinants of inadequate prenatal care utilization by African American women

Fewer African-American women living in urban communities are likely to get adequate prenatal care during their pregnancy than white women are, a new study finds, and the main reason could be their negative views about the need for such care.

6 Aug 2007

Tailor-made antidepressants

In spite that the causes of depression have not still been fully identified, scientists acknowledge that genetic and environmental factors play a common role in the onset of this disorder.

6 Aug 2007

Be aware! whispering stroke all too common

Scientists in the U.S. say some people experience subtle symptoms which are suggestive of a stroke without an actual stroke being diagnosed.

6 Aug 2007

Unlocking proteins from their cellular shell

Applying physical stress to cells, researchers at the University of Pennsylvania have demonstrated that everyday forces can alter the structure of proteins tucked within cells, unfold them and expose new targets in the fight against disease.

3 Aug 2007

HMGB1 protein shown to act as an accelerator - activating the body's defenses

Toll-like receptors are the guard dogs of the immune system, sniffing out bacteria and viruses then activating the body's immune system for an attack on these invaders.

3 Aug 2007

Innovative gene therapy research for muscular dystrophy

A major grant of approximately $10 million from the National Institutes of Health will help investigators at Columbus Children's Research Institute (CCRI) at Columbus Children's Hospital learn more about strategies to treat muscular dystrophy, potentially leading to two new gene therapy approaches.

3 Aug 2007

New diagnostic tool to detect infection-causing bacteria

Infection-causing bacteria can't hide from researchers at Northern Arizona University, who recently helped develop the first diagnostic tool to detect them.

3 Aug 2007

Integrated system, rapid transfer offers lifeline for heart attack victims

Heart attack patients received lifesaving treatment quickly when hospitals and communities used an integrated, rapid transfer system to get patients to a facility equipped to perform artery-opening procedures, according to a report in Circulation: Journal of the American Heart Association.

3 Aug 2007

Gastroenterologist-directed sedation safe and effective for endoscopic procedures

The use of an evidence-based sedation protocol for endoscopic procedures improves the quality of practice and reduces the incidence of sedation-related adverse events, according to an AGA Institute Review of Endoscopic Sedation published in the August issue of Gastroenterology , the official journal of the American Gastroenterological Association (AGA) Institute.

3 Aug 2007

FDA, DoD collaborate on regulated drugs, biologics, and medical devices

Data from the U.S. Military Health System will soon help the U.S. Food and Drug Administration make decisions affecting the safety and use of FDA-regulated products for all Americans.

3 Aug 2007

Jump in cancer-related clots

Blood clots are increasingly common in cancer patients, but University of Rochester Medical Center researchers have created a novel risk model that can predict, with 98 percent certainty, which patients will not get a blood clot.

3 Aug 2007

Cognitive impairment link found in popular acid blockers

Long-term use of histamine2 receptor antagonists (H2A), one class of drugs that blocks stomach acid, may be associated with cognitive impairment in older African-American adults.

3 Aug 2007

CDC to provide intravenous artesunate for treatment of severe malaria

The Centers for Disease Control and Prevention (CDC) has received permission from the Food and Drug Administration (FDA) to provide intravenous artesunate for emergency use in the United States for persons with severe malaria.

3 Aug 2007

Possible anthrax drug targets

In the American government's biodefense efforts, the potential for terrorists to cause a deadly anthrax outbreak remains a significant concern, six years after the letter attacks that shook the nation shortly after 9/11.

3 Aug 2007

New pregnancy labeling rules should be approved without delay

Marks the tenth anniversary of a public hearing that was hoped to spark substantial changes in the way drugs are labeled for use during pregnancy.

2 Aug 2007

Genta and Emisphere Technologies file investigational new drug exemption

Genta Inc. and Emisphere Technologies, Inc. have jointly announced the submission of an Investigational New Drug Exemption (IND) to the Endocrinologic and Metabolic Drugs Division of the U.S. Food and Drug Administration (FDA) for a new drug known as G4544.

2 Aug 2007

Statins don't offset healthy choices

Within the medical field, it is often assumed that patients view cholesterol-lowering medications (or statins) as a license to eat whatever they like -- they figure their medication has them covered, so a steak here and there won't hurt.

2 Aug 2007

ARIUS announces allowance of US patent for lead anti-cancer antibody

ARIUS Research Inc., has announced that the Company has received notice from the United States Patent and Trademark Office that a key patent for its lead anti-CD44 drug candidate will issue on August 7th, 2007, as US Patent Number 7,252,821.

2 Aug 2007